Results 191 to 200 of about 5,061,309 (249)
Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort
International Journal of Cancer, Volume 159, Issue 9, Page 2146-2157, 1 November 2026.The immune system has been implicated as a major driver in pancreatic cancer etiology. Previous cohort studies have found associations between pancreatic cancer and single immune system‐derived markers, but omics‐based evidence remains scarce. In this prospective case–control study, the authors investigated 92 proteins involved in immune reactions and ...Verena A. Katzke, Yue Chen, Srimanti Dutta, Federico Canzian, Julie Louise Munk Andersen, Agnetha Linn Rostgaard‐Hansen, Léa Bouteille, Vinciane Rebours, Thérèse Truong, Matthias B. Schulze, Benedetta Bendinelli, Valeria Pala, Vittorio Simeon, Rosario Tumino, Carlotta Sacerdote, Roel Vermeulen, P. Martijn Kolijn, Sjoerd G. Elias, Marta Crous‐Bou, Maria‐José Sánchez, Ana Jimenez‐Zabala, José María Huerta, Marcela Guevara, Nick Wareham, Marie Breeur, Mattias Johansson, James Yarmolinsky, Daniele Campa, Rudolf Kaaks +28 morewiley +1 more sourceCorrection: understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample. [PDF]
J Eat DisordGawron LP, Garrido-Ribas I, Carmona-Farrés C, Carril-Batuecas S, Carceller-Sindreu M, Avila-Parcet A, Amaro-Carriba MA, Hernández-Molina M, Portella MJ, Pousa E, Insight Barcelona Work Group. +10 moreeuropepmc +1 more sourceStandardized Microplate‐Based Assays for Quantifying Antioxidant Activity in Extracellular Vesicles and Nanovesicles Across Biological Kingdoms
Journal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.ABSTRACT
The antioxidant activity of extracellular vesicles (EVs) and nanovesicles are increasingly linked to their physiological and therapeutic functions, yet its accurate quantification remains limited by low EV yield, co‐isolated contaminants and the lack of standardized methodologies.Juan Antonio Nieto, María‐Carmen López de las Hazas, Victoria Martín‐Santiago, Laura Rubio‐Silvan, Carmen Mazarío‐Gárgoles, Ludovica Attanasio, Benedetta Mercuriali, João Tomé‐Carneiro, Giulia Bernabè, Andrea del Saz‐Lara, Carmen Crespo, María Ángeles Ávila‐Gálvez, Emma Burgos‐Ramos, Juan Carlos Espín, Andrea Chini, Alberto Dávalos +15 morewiley +1 more sourceScaling of an evidence-based intervention program in older people with diabetes and frailty in Latin America. Diabfrail-Latam clinical trial protocol. [PDF]
J Frailty AgingLaosa O, Cano-Gutierrez CA, Sepulveda-Loyola W, Morsch P, Vega E, Parodi JF, Zuñiga C, Aruachan S, Luque J, Araya-Quintanilla F, Osorio N, Calvani R, Picca A, Peña-Longobardo L, Pedraza L, Izquierdo M, Gomez-Cabrera MC, Viña J, Rol MA, Sinclair AJ, Rodriguez-Mañas L. +20 moreeuropepmc +1 more sourceFatty Acid Oxidation Disorders Detected by Newborn Screening: Clinical, Biochemical and Genetic Spectrum in a Single‐Center Cohort
JIMD Reports, Volume 67, Issue 6, November 2026.ABSTRACT
Newborn screening (NBS) has significantly improved early detection and survival in fatty acid oxidation disorders (FAODs). However, the expanding phenotypic spectrum challenges prognostic stratification, and long‐term morbidity remains incompletely characterized.Elena Martín‐Hernández, Delia Barrio‐Carreras, María Martín‐Cazaña, Luis Miguel García‐Cárdaba, Carmen Martín‐Fernández, Patricia Pérez‐Mohand, Teresa Hernández Chamorro, Berta Zamora Crespo, Pedro Ruiz‐Sala, Patricia Alcaide Alonso, Pilar Quijada‐Fraile +10 morewiley +1 more sourceTemporal Trends in Janus Kinase Inhibitor (JAKi) Use Across Five European Countries: A DARWIN EU Network Study
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.ABSTRACT Introduction
Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.Xihang Chen, Andrei Barbulescu, George Corby, Saeed Hayati, Annika Jodicke, Toni Lehtonen, Hedvig Marie Egeland Nordeng, Alexandra Pacurariu, Gabriel Sanfélix‐Gimeno, Nhung T. H. Trinh, Katia Verhamme, Dina Vojinovic, Daniel Prieto‐Alhambra, Amy Shuk‐Man Lam, Edward Burn +14 morewiley +1 more sourceIntestinal Permeability in Irritable Bowel Syndrome With and Without Comorbid Conditions: Results From the European DISCOvERIE Cohort
United European Gastroenterology Journal, Volume 14, Issue 9, November 2026.ABSTRACT Background
Irritable bowel syndrome (IBS) is a disorder of gut‐brain interaction often accompanied by psychiatric and/or somatic comorbidities. Intestinal‐barrier dysfunction has been implicated in IBS pathophysiology. However, the contribution of psychiatric and somatic comorbidities to intestinal permeability remains unclear.Alice Rustichelli, Juan Manuel Garcia‐Illarramendi, Javier Santos, Ana Maria González‐Castro, Magnus Simrén, Irina Midenfjord, Amanda Rodriguez‐Urrutia, Elba Expósito, Beatriz Lobo, Jose Alegre‐Martin, Miriam Almirall, Jesús Castro‐Marrero, Ramon Sanmartin‐Sentañes, Jan Tack, Florencia Carbone, Lukas Van Oudenhove, Maaike Van Den Houte, Liene Bervoets, Sybren Rinckhout, Daisy Jonkers, Michelle Bosman, Maria Raffaella Barbaro, Giovanni Barbara, Istvan Bitter, Eva Jekkel, Andreas Reif, Mareike Aichholzer, Carmen Uckermark, Alejandro Arias Vasquez, Dan Lucian Dumitrascu, Andrei‐Vasile Pop, Kristin Verbeke, Carmen Alonso‐Cotoner, Ricard Farré +33 morewiley +1 more sourceImpact of Prior Biologic Mechanism of Action on Anti‐TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1234-1247, November 2026.In this nationwide ENEIDA registry study, anti‐TNF therapy after prior exposure to a different biologic mechanism of action showed reduced treatment durability in inflammatory bowel disease, with a particularly marked impact in ulcerative colitis, where short‐ and long‐term clinical effectiveness was also lower. ABSTRACT Background
The expanding use of Carmen Yagüe Caballero, Santiago García López, Ana Royo Esteban, Laura Figueras Panillo, Pilar Nos, Luisa de Castro, M. Dolores Martín‐Arranz, Manuel Barreiro‐de Acosta, Elena Ricart, Ruth de Francisco, Eva Iglesias, Antonio Giordano, Pilar Varela, Iago Rodríguez‐Lago, Montserrat Rivero, Beatriz Sicilia, Merce Navarro‐Llavat, Isabel Vera, Carles Suria, Jordi Guardiola, Jesús Barrio, Margalida Calafat, Ana Gutiérrez, Xavier Calvet, David Rafael de la Cruz, Francisco Mesonero, Cristina Martínez Pascual, Javier P. Gisbert, Carla J. Gargallo‐Puyuelo, David Monfort i Miquel, Mónica Sierra, Laura Arranz, Cristina Rodríguez‐Gutiérrez, Rufo Lorente, Fernando Bermejo, Lucía Márquez‐Mosquera, Gisela Torres Vicente, José Lázaro Pérez‐Calle, José M. Huguet, Laura Ramos, Ángel Ponferrada‐Díaz, Daniel Ceballos, Mª. Teresa Diz‐Lois Palomares, Eva Sesé Abizanda, Pablo Vega, Ramón Pajares, Javier Santos Fernández, Elena Betoré, David Busquets, Olga Merino, Carlos Martínez‐Flores, Yamile Zabana, Manuela Josefa Sampedro González, Jone Ortiz de Zarate, Ana Fuentes Coronel, Empar Sainz Arnau, Daniel Carpio, Nuria Jiménez, Ignacio Marín‐Jiménez, Luis Bujanda, Raquel Camargo Camero, Martín Irabien, María Abanades Tercero, Benito Velayos Jiménez, Pilar Robledo Andres, Ana María Trapero, Pedro G. Delgado‐Guillena, Luís Hernández Villalba, Margarita Menacho, Nuria Rull Murillo, Carles Leal, Cristina Alba, Rosa Gómez Espín, Alfredo J. Lucendo, Manuel Van Domselaar, Laura García Alles, Eduardo Iyo Miyashiro, Ana Crespo Catalá, Pau Gilabert, Daniel Martín Rodríguez, Víctor Manuel Navas‐López, María Calvo Iñiguez, Daniel Ginard, Teresa Martínez Pérez, Eugeni Domènech, Diego Casas Deza +85 morewiley +1 more source